Finance

Lists
Why is 000100 up 7,84%?
Dive Deeper
000100:KRX
Yuhan Corp
₩86 700,00
+7,84%
(+6 300,00) 1D
19 Okt., 12:35:41 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 000100...
Open
₩80 500
High
₩87 100
Low
₩79 800
Mkt. cap
6,47 bn
Avg. vol.
207,75 k
Volume
585,98 k
Dividend
0,69%
Quarterly dividend
₩150
Ex-dividend date
26 Feb. 2026
P/E ratio
27,25
52-wk high
₩129 200
52-wk low
₩65 000
EPS
₩3 181
Shares outstanding
73,62 m
No. of employees
2 k
Open
₩80 500
High
₩87 100
Low
₩79 800
Mkt. cap
6,47 bn
Avg. vol.
207,75 k
Volume
585,98 k
Dividend
0,69%
Quarterly dividend
₩150
Ex-dividend date
26 Feb. 2026
P/E ratio
27,25
52-wk high
₩129 200
52-wk low
₩65 000
EPS
₩3 181
Shares outstanding
73,62 m
No. of employees
2 k
News stories
From web sources and news partners
Profile
Yuhan Corporation is a South Korean pharmaceutical and chemical company headquartered in Daebang-dong, Dongjak-gu, Seoul. It was established in 1926 by New Il-han and has been listed on the Korea Stock Exchange since 1962. Yuhan is one of the top Korean pharmaceutical companies, along with Celltrion, Samsung Biologics, GC Pharma, and Hanmi Pharmaceutical. Wikipedia
About Yuhan Corp
CEOWook Je Cho
Employees2,08 k
Founded1926
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
570,01 mjd
546,07 mjd
526,78 mjd
639,45 mjd
Cost of goods sold
401,57 mjd
333,27 mjd
377,63 mjd
411,75 mjd
Cost of revenue
401,57 mjd
333,27 mjd
377,63 mjd
411,75 mjd
Research and development expenses
45,94 mjd
78,04 mjd
47,24 mjd
60,12 mjd
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
94,69 mjd
103,16 mjd
88,43 mjd
99,40 mjd
Operating expense
146,43 mjd
185,79 mjd
140,37 mjd
160,70 mjd
Total operating expenses
548,00 mjd
519,05 mjd
518,00 mjd
572,45 mjd
Operating income
22,01 mjd
27,02 mjd
8,78 mjd
67,00 mjd
Other non operating income
-2,09 mjd
-4,58 mjd
231,25 m
-6,59 mjd
EBT including unusual items
35,18 mjd
120,91 mjd
28,76 mjd
88,37 mjd
EBT excluding unusual items
34,24 mjd
112,36 mjd
26,45 mjd
84,89 mjd
Income tax expense
14,01 mjd
10,77 mjd
5,39 mjd
20,33 mjd
Effective tax rate
39,83%
8,91%
18,75%
23,00%
Other operating expenses
1,68 mjd
3,00 mjd
1,94 mjd
2,87 mjd
Net income
25,28 mjd
114,43 mjd
27,04 mjd
70,32 mjd
Net profit margin
4,44%
20,96%
5,13%
11,00%
Earnings per share
348,00
1,53 k
372,00
950,00
Interest and investment income
2,11 mjd
2,13 mjd
2,35 mjd
2,47 mjd
Interest expense
-3,99 mjd
-3,91 mjd
-3,86 mjd
-3,89 mjd
Net interest expenses
-1,88 mjd
-1,77 mjd
-1,51 mjd
-1,42 mjd
Depreciation and amortization charges
2,12 mjd
962,24 m
1,52 mjd
1,48 mjd
EBITDA
40,00 mjd
44,17 mjd
27,88 mjd
90,47 mjd
Gain or loss from assets sale
9,44 m
-9,65 mjd
15,64 m
291,06 m
AI content may include mistakes. Learn more
Google-programme